Schizophrenia & Psychosis Action Alliance

📣 📣 📣 New resource available! Many in our community are using our “I’m Diagnosed. Now What?” toolkit to help navigate their disease with practical advice, resources and encouragement. Today, we’re launching companion worksheets that help bring the toolkit concepts to life: https://bit.ly/4ez19ZD The worksheets are designed to empower diagnosed people, caregivers and clinicians to navigate the #schizophrenia recovery journey together. (There are versions for those diagnosed and caregivers.) They allow you to reflect on what’s happening in your life and then share that with one another. In a world where so much of our care system is siloed or broken, these worksheets are designed to create connection and healing. Check them out and let us know what you think! https://bit.ly/4ez19ZD

Imagine you’ve just started college, with a promising path ahead. Suddenly, you develop frightening symptoms with no explanation. You’re forced to quit school. Now imagine you’re the parent in this situation, watching your loved one disappear in front of your eyes. The road to successful diagnosis, treatment and recovery from this severe brain disease is long and difficult. Our new monthly giving community, The Hope Circle, will help ensure everyone with #schizophrenia and #psychosis – and those who care for them – has the resources they need on the path to recovery: https://lnkd.in/eqNNMvKM. We’re launching powerful new programs to help shatter the barriers to recovery. The Hope Circle creates the power surge needed to drive results.  When you join The Hope Circle, you’re investing in your loved one’s future and in yourself – and powering our investment in research, education and advocacy that will create lasting solutions. See how your monthly gift can power the future: https://lnkd.in/eqNNMvKM

LAST DAY to get the Early Bird rate! Join us May 14-15 in Washington, D.C., for our 2nd annual SPRING Summit. We’ll explore strategies, programs, education and research ideas that contribute to our community goal: shattering the barriers to treatment, survival and recovery for people living with #schizophrenia. The Early Bird rate ends TODAY, so register now to get the discount: https://bit.ly/4ijZPvz. Those diagnosed can register for only $25 using the code AccessForAll – but only through today. Secure your seat now to ensure your voice is heard! We can’t wait to see you.

🎉🎉🎉 Just released! Our 2024 Annual Report showcases our impact on behalf of the #schizophrenia and #psychosis community in our key strategic areas of Research, Education & Care and Advocacy & Public Policy. It was a groundbreaking year, and we’ve never been more confident about the future. Recovery is a real and achievable goal for people with schizophrenia; we’re working every day to make it possible for everyone. And of course, we couldn’t do it without you. Read our Annual Report here: https://bit.ly/43YPsIZ

Read the insights of our Director of Research and Scientific Affairs, Dr. Arundati Nagendra, in this new white paper from Mesmerize on breaking barriers to care for people living with schizophrenia. An important part of our work is to ensure the experiences and voices of our community are heard by those developing treatments and policies that affect people with this serious brain disease.

⏰ Just a few more days to get the Early Bird rate! Join us May 14-15 in Washington, D.C., for our 2nd annual SPRING Summit. We’ll explore strategies, programs, education and research ideas that contribute to our community goal: shattering the barriers to treatment, survival and recovery.  The Early Bird rate ends March 31, so register now to get the discount: https://bit.ly/4ijZPvz. Those diagnosed can register for only $25 using the code AccessForAll – but only until March 31. Secure your seat now to ensure your voice is heard!

Does FDA’s elimination of the #clozapine #REMS requirements have you wondering what to do next? Join us for a webinar this Wednesday at noon ET, when we’ll discuss the implications of FDA’s momentous decision. Our panel of experts will talk about what pharmacies, prescribers and insurance companies can do to help make clozapine accessible to the people who need it – and what people with #schizophrenia can do in the meantime. Register now to secure your spot: https://bit.ly/4i1Scd5

Did you miss one of our popular “Innovations in Treatment” webinars? Did you like the webinars and want to revisit one or more of them? Good news: recordings of all 3 webinars are available on our website: https://lnkd.in/ebP6PYua. This webinar series explores how innovations in #schizophrenia treatment can help people manage their disease and how clinicians can work with their patients to achieve meaningful treatment outcomes. Each webinar explores a different topic: positive symptoms, negative symptoms and the cognitive impact of the disease. Featured speakers use plain language to ensure all participants can understand and act on the information shared. Visit our website to watch them at your convenience! https://lnkd.in/ebP6PYua

Does FDA’s elimination of the clozapine REMS requirements have you wondering what to do next? Join us for a webinar on Wednesday, March 12 at noon ET, when we’ll discuss the implications of FDA’s momentous decision. Our panel of experts will talk about what pharmacies, prescribers and insurance companies can do to help make clozapine accessible to the people who need it – and what people with schizophrenia can do in the meantime. Register now to secure your spot: https://bit.ly/4i1Scd5

Just released! Our Schizophrenia Medicines in Jeopardy report highlights a dangerous unintended consequence of the Inflation Reduction Act: threatening the development of new medicines for people with schizophrenia. The IRA was designed in part to lower medicine prices. But our report details how it unfairly targets the type of medicine that people with schizophrenia rely on. Our community cannot afford more barriers to effective treatment. Read the report to learn more: https://bit.ly/3QCRmHn